# ABCA7

## Overview
ABCA7 is a gene that encodes the ATP-binding cassette subfamily A member 7 (ABCA7) protein, which is a transmembrane transporter involved in lipid transport and homeostasis. The ABCA7 protein is a member of the ATP-binding cassette (ABC) transporter family, characterized by its two transmembrane domains and two nucleotide-binding domains, which facilitate the ATP-dependent translocation of substrates across cellular membranes (Kaminski2006ABC). Functionally, ABCA7 is implicated in the efflux of phospholipids and plays a significant role in the formation of high-density lipoprotein (HDL) particles, as well as in the process of phagocytosis, particularly in reticuloendothelial tissues (AbeDohmae2004Human; Iwamoto2006ABCA7). The gene has garnered attention for its association with Alzheimer's disease, where certain genetic variants are linked to an increased risk of developing the condition, highlighting its importance in both lipid metabolism and neurodegenerative disease pathogenesis (Bossaerts2022The; Stepler2022ABCA7).

## Structure
The ABCA7 protein is a full-size ABC transporter composed of 2146 amino acids, with a calculated molecular weight of approximately 220 kDa (Kaminski2006ABC). Its primary structure includes two transmembrane domains (TMDs), each containing six membrane-spanning α-helices, and two nucleotide-binding domains (NBDs) with conserved Walker A and B motifs (Kaminski2000Genomic; Kaminski2006ABC). The protein also features a large extracellular domain (ECD) and a regulatory domain (RD) (Le2021Capturing).

The secondary structure of ABCA7 is characterized by the presence of α-helices within the TMDs, which are crucial for its function as a transporter (Kaminski2006ABC). The tertiary structure involves the folding of these domains, allowing for the formation of a functional transporter capable of substrate translocation (Le2021Capturing).

ABCA7's quaternary structure is defined by its assembly into a full transporter, with two halves each containing a TMD, NBD, and ECD (Le2021Capturing). The protein undergoes conformational changes during its ATP-dependent transport cycle, influenced by its lipid environment (Le2021Capturing). Post-translational modifications such as glycosylation are suggested by the presence of glycosylation sites in the ECD (Le2021Capturing).

## Function
ABCA7 is a member of the ATP-binding cassette (ABC) transporter family, specifically involved in lipid transport and homeostasis. It plays a crucial role in the apolipoprotein-mediated release of cellular cholesterol and phospholipids, contributing to the formation of high-density lipoprotein (HDL) in human cells (AbeDohmae2004Human). Unlike ABCA1, which is involved in both cholesterol and phospholipid efflux, ABCA7 primarily facilitates phospholipid efflux and has a distinct substrate specificity (Wang2003ATPbinding).

ABCA7 is also associated with phagocytosis, a critical cellular function for responding to infection, injury, and apoptosis. It is highly expressed in reticuloendothelial tissues and promotes Fc receptor-independent phagocytosis (Tanaka2011Roles; Iwamoto2006ABCA7). The expression of ABCA7 is regulated by cellular cholesterol levels through the sterol-responsive element binding protein 2 (SREBP2) pathway, with its expression being upregulated by cholesterol depletion (Iwamoto2006ABCA7).

ABCA7 is primarily localized in the plasma membrane but can also be found in intracellular membranes. It is glycosylated, similar to other ABC transporters like ABCA1 (Tanaka2011Roles). The protein's role in lipid metabolism and immune response highlights its importance in maintaining cellular lipid balance and facilitating the clearance of particles through phagocytosis.

## Clinical Significance
Mutations and alterations in the ABCA7 gene are significantly associated with Alzheimer's disease (AD), particularly late-onset Alzheimer's disease (LOAD). Genome-wide association studies have identified both common and rare variants in ABCA7 that increase the risk of AD. Common single nucleotide polymorphisms (SNPs) such as rs3764650 and rs3752232 are linked to an increased risk of AD, with some variants increasing the risk by up to 50% (Stepler2022ABCA7). Rare mutations, including frameshift and nonsense mutations, are enriched in AD patients and can lead to premature termination codons, resulting in loss-of-function due to nonsense-mediated decay (Bossaerts2022The; De2019The).

ABCA7 is involved in lipid metabolism and phagocytosis, processes that are disrupted in AD. Loss of ABCA7 function can lead to increased amyloid-beta (Aβ) production and impaired clearance, contributing to amyloid plaque accumulation in the brain (Satoh2015ATPbinding; Kim2013Deletion). In African American populations, certain ABCA7 variants are associated with a higher risk of AD, with an effect size comparable to the APOE ε4 allele (Stepler2022ABCA7). These genetic variations can also affect brain morphology and cognitive decline, highlighting the gene's role in AD pathogenesis (Stepler2022ABCA7).

## Interactions
ABCA7 interacts with several proteins, playing a significant role in lipid metabolism and phagocytosis. It binds apolipoprotein A-I (apoA-I) at the cell surface, facilitating the efflux of phospholipids such as phosphatidylcholine and sphingomyelin, but not cholesterol (Wang2003ATPbinding). This interaction is specific, as demonstrated by chemical cross-linking experiments and competitive binding assays (Wang2003ATPbinding).

ABCA7 also interacts with low-density lipoprotein receptor-related protein 1 (LRP1) during the phagocytosis of apoptotic cells. This interaction is crucial for the redistribution of ABCA7 and LRP1 to the phagocytic cup, enhancing the phagocytosis process and associated ERK signaling in macrophages (Jehle2006ATPbinding). The interaction with LRP1 is significant for the cell surface expression of both proteins, which is essential for effective phagocytosis (Jehle2006ATPbinding).

In the context of Alzheimer's disease, ABCA7 is suggested to modulate amyloid precursor protein (APP) processing and amyloid-β (Aβ) production through its interaction with LRP1, potentially affecting Aβ homeostasis and contributing to disease pathogenesis (Satoh2015ATPbinding; Zhao2014ABCA7).


## References


[1. (Kaminski2000Genomic) Wolfgang E. Kaminski, Armin Piehler, and Gerd Schmitz. Genomic organization of the human cholesterol-responsive abc transporter abca7: tandem linkage with the minor histocompatibility antigen ha-1 gene. Biochemical and Biophysical Research Communications, 278(3):782–789, November 2000. URL: http://dx.doi.org/10.1006/BBRC.2000.3880, doi:10.1006/bbrc.2000.3880. This article has 39 citations and is from a peer-reviewed journal.](https://doi.org/10.1006/BBRC.2000.3880)

[2. (Satoh2015ATPbinding) Kanayo Satoh, Sumiko Abe-Dohmae, Shinji Yokoyama, Peter St George-Hyslop, and Paul E. Fraser. Atp-binding cassette transporter a7 (abca7) loss of function alters alzheimer amyloid processing. Journal of Biological Chemistry, 290(40):24152–24165, October 2015. URL: http://dx.doi.org/10.1074/jbc.M115.655076, doi:10.1074/jbc.m115.655076. This article has 137 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.M115.655076)

[3. (Kim2013Deletion) Woojin S. Kim, Hongyun Li, Kalani Ruberu, Sharon Chan, David A. Elliott, Jac Kee Low, David Cheng, Tim Karl, and Brett Garner. Deletion ofabca7increases cerebral amyloid-β accumulation in the j20 mouse model of alzheimer’s disease. The Journal of Neuroscience, 33(10):4387–4394, March 2013. URL: http://dx.doi.org/10.1523/jneurosci.4165-12.2013, doi:10.1523/jneurosci.4165-12.2013. This article has 162 citations.](https://doi.org/10.1523/jneurosci.4165-12.2013)

4. (Le2021Capturing) Capturing the interplay of membrane lipids and structural transitions in human ABCA7. This article has 1 citations.

[5. (Zhao2014ABCA7) Qing-Fei Zhao, Jin-Tai Yu, Meng-Shan Tan, and Lan Tan. Abca7 in alzheimer’s disease. Molecular Neurobiology, 51(3):1008–1016, May 2014. URL: http://dx.doi.org/10.1007/s12035-014-8759-9, doi:10.1007/s12035-014-8759-9. This article has 29 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s12035-014-8759-9)

[6. (Bossaerts2022The) Liene Bossaerts, Rita Cacace, and Christine Van Broeckhoven. The role of atp-binding cassette subfamily a in the etiology of alzheimer’s disease. Molecular Neurodegeneration, April 2022. URL: http://dx.doi.org/10.1186/s13024-022-00536-w, doi:10.1186/s13024-022-00536-w. This article has 27 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1186/s13024-022-00536-w)

[7. (Iwamoto2006ABCA7) Noriyuki Iwamoto, Sumiko Abe-Dohmae, Ryuichiro Sato, and Shinji Yokoyama. Abca7 expression is regulated by cellular cholesterol through the srebp2 pathway and associated with phagocytosis. Journal of Lipid Research, 47(9):1915–1927, September 2006. URL: http://dx.doi.org/10.1194/jlr.m600127-jlr200, doi:10.1194/jlr.m600127-jlr200. This article has 86 citations and is from a peer-reviewed journal.](https://doi.org/10.1194/jlr.m600127-jlr200)

[8. (Kaminski2006ABC) Wolfgang E. Kaminski, Armin Piehler, and Jürgen J. Wenzel. Abc a-subfamily transporters: structure, function and disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1762(5):510–524, May 2006. URL: http://dx.doi.org/10.1016/j.bbadis.2006.01.011, doi:10.1016/j.bbadis.2006.01.011. This article has 147 citations.](https://doi.org/10.1016/j.bbadis.2006.01.011)

[9. (Tanaka2011Roles) Nobukiyo Tanaka, Sumiko Abe-Dohmae, Noriyuki Iwamoto, and Shinji Yokoyama. Roles of atp-binding cassette transporter a7 in cholesterol homeostasis and host defense system. Journal of Atherosclerosis and Thrombosis, 18(4):274–281, 2011. URL: http://dx.doi.org/10.5551/jat.6726, doi:10.5551/jat.6726. This article has 57 citations and is from a peer-reviewed journal.](https://doi.org/10.5551/jat.6726)

[10. (De2019The) Arne De Roeck, Christine Van Broeckhoven, and Kristel Sleegers. The role of abca7 in alzheimer’s disease: evidence from genomics, transcriptomics and methylomics. Acta Neuropathologica, 138(2):201–220, March 2019. URL: http://dx.doi.org/10.1007/s00401-019-01994-1, doi:10.1007/s00401-019-01994-1. This article has 136 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1007/s00401-019-01994-1)

[11. (Jehle2006ATPbinding) Andreas W. Jehle, Shyra J. Gardai, Suzhao Li, Patrick Linsel-Nitschke, Konosuke Morimoto, William J. Janssen, R. William Vandivier, Nan Wang, Steven Greenberg, Benjamin M. Dale, Chunbo Qin, Peter M. Henson, and Alan R. Tall. Atp-binding cassette transporter a7 enhances phagocytosis of apoptotic cells and associated erk signaling in macrophages. The Journal of Cell Biology, 174(4):547–556, August 2006. URL: http://dx.doi.org/10.1083/jcb.200601030, doi:10.1083/jcb.200601030. This article has 165 citations.](https://doi.org/10.1083/jcb.200601030)

[12. (AbeDohmae2004Human) Sumiko Abe-Dohmae, Yuika Ikeda, Michinori Matsuo, Michi Hayashi, Kei-ichiro Okuhira, Kazumitsu Ueda, and Shinji Yokoyama. Human abca7 supports apolipoprotein-mediated release of cellular cholesterol and phospholipid to generate high density lipoprotein. Journal of Biological Chemistry, 279(1):604–611, January 2004. URL: http://dx.doi.org/10.1074/jbc.m309888200, doi:10.1074/jbc.m309888200. This article has 157 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m309888200)

[13. (Stepler2022ABCA7) Kaitlyn E. Stepler, Taneisha R. Gillyard, Calla B. Reed, Tyra M. Avery, Jamaine S. Davis, and Renã A.S. Robinson. Abca7, a genetic risk factor associated with alzheimer’s disease risk in african americans. Journal of Alzheimer’s Disease, 86(1):5–19, March 2022. URL: http://dx.doi.org/10.3233/jad-215306, doi:10.3233/jad-215306. This article has 12 citations.](https://doi.org/10.3233/jad-215306)

[14. (Wang2003ATPbinding) Nan Wang, Debin Lan, Marie Gerbod-Giannone, Patrick Linsel-Nitschke, Andreas Werner Jehle, Wengen Chen, Laurent O. Martinez, and Alan R. Tall. Atp-binding cassette transporter a7 (abca7) binds apolipoprotein a-i and mediates cellular phospholipid but not cholesterol efflux. Journal of Biological Chemistry, 278(44):42906–42912, October 2003. URL: http://dx.doi.org/10.1074/jbc.M307831200, doi:10.1074/jbc.m307831200. This article has 230 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.M307831200)